https://de.marketscreener.com/kurs/aktie/SEELOS-THERAPEUTICS-INC-53920921/news/ALS-Behandlung-von-Seelos-Therapeutics-scheitert-im-mittleren-Stadium-der-Studie-46231390/?utm_source=telegram&utm_medium=social&utm_campaign=share